Pfizer/Merck KGaA launch solid tumor combo study with Leap; AstraZeneca and Immunomedics to test ADC cancer combo
→ Pfizer and Merck KGaA are teaming up with Leap Therapeutics $LPTX to evaluate the small Cambridge, MA-based company’s drug in a combo with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
